| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 23, 2013 | New Constructs, LLC | N/A | PFE: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 23, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - PFIZER INC. (PFE-N) | 12 | $25 | | May 23, 2013 | Stock Traders Daily | Thomas H Kee Jr. | Trading Report for (PFE). A detailed report, including free correlated market analysis, and updates. | 5 | $57.50 | | May 23, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Large CAP Pharma | 17 | $195.50 | | May 23, 2013 | Jefferson Research | N/A | Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of PFIZER INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 11 | $20 | | May 23, 2013 | Alpha Street Research | Hunter Orr | PFE - Pfizer Inc - Upgraded to a Buy - Company Analysis and ASR Ranking Report | 9 | $24 | | May 22, 2013 | Plunkett Research, Ltd. | Jack W Plunkett | Pfizer Inc (PFE) Profile and Financials, plus Nanotechnology Industry Trends Analysis, Operating Ratios and Financial Averages | 32 | $99 | | May 22, 2013 | Plunkett Research, Ltd. | Jack W Plunkett | Pfizer Inc (PFE) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratios and Financial Averages | 49 | $99 | | May 22, 2013 | Plunkett Research, Ltd. | Jack W Plunkett | Pfizer Inc (PFE) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratios and Financial Averages | 52 | $99 | | May 22, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for PFE | 11 | $126.50 |
|
View All Reports for PFE ... |
|
|
0.07(0.24%) 4:00PM EDT|After Hours
:
28.83